Sagimet Biosciences Inc. Shares Outstanding (Cover Page)
Sagimet Biosciences Inc. (SGMT) had Shares Outstanding (Cover Page) of 30.67 million shares as of 2024-11-08, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2024-11-14
- 2024-11-08: Entity Common Stock, Shares Outstanding 30.67M shares.
- 2024-08-09: Entity Common Stock, Shares Outstanding 30.67M shares.
- 2024-05-10: Entity Common Stock, Shares Outstanding 30.39M shares.
- 2023-11-09: Entity Common Stock, Shares Outstanding 21.38M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2024-11-08 | 30.67M shares 10-Q · filed 2024-11-14 |
| 2024-08-09 | 30.67M shares 10-Q · filed 2024-08-14 |
| 2024-05-10 | 30.39M shares 10-Q · filed 2024-05-15 |
| 2023-11-09 | 21.38M shares 10-Q · filed 2023-11-13 |
| 2023-08-16 | 21.35M shares 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |